Gabapentine

PreclinicalSmall molecule

AAssistance Publique - Hôpitaux de Paris

Gabapentine is one of 9 small molecule programs targeting Bruxism. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

BruxismActive, not recruiting

BruxismPreclinical

Active, not recruiting

Competition

Competitive Landscape

10 competitors in Bruxism

#DrugCompanyPhaseTrials

Botox

RRevance Therapeutics, Inc.

Approved

3 2

Advil

KKenvue Brands

Approved

1 3

Paraflex

WWim Janssens

Approved

1 4

Botox

AbbVie

Preclinical

2 5

Pharmacotherapy

UUniversity of Pittsburgh

Preclinical

1 6

Dysport

GGalderma R&D

Preclinical

1 7

Gabapentine

AAssistance Publique - Hôpitaux de Paris

Preclinical

1 8

Opipramol

WWroclaw Medical University

Preclinical

1 9

Prabotulinumtoxina

UUniversity of Southern California

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Bruxism1 trial

Comparative Evaluation of Gabapentine and Occlusal Splint in the Management of Sleep Bruxism

Completed·MMashhad University of Medical Sciences·N/A·NCT01255878·20 enrolled

Preoperative1 trial

Preoperative Gabapentine for Carpal Tunnel

Completed·FFederal University of São Paulo·Phase 3·NCT01632215·40 enrolled

Pediatrics1 trial

Population Pharmacokinetics of Antiepileptic in Pediatrics

Completed·AAssistance Publique - Hôpitaux de Paris··NCT03196466·753 enrolled

Herpes Zoster1 trial

Acupuncture in Herpes Zoster Neuralgia (ACUZoster)

Completed·DDominik Irnich·Phase 4·NCT00885586·68 enrolled

Sources

References

[1]
ClinicalTrials.gov — 4 trial records for Gabapentine. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Gabapentine compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Gabapentine. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Assistance Publique - Hôpitaux de Paris company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: AAssistance Publique - Hôpitaux de Paris

Gabapentine

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Bruxism1 trial

Preoperative1 trial

Pediatrics1 trial

Herpes Zoster1 trial

References

Drug Info

Quick Facts

Related News